Metabolic Health Consequences of Switching to the Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir Plus Lamivudine Regimens in Virologically Suppressed People Living with HIV Aged > 40 Years: A Retrospective Real-World Study

Shi J, Zhang W, Han J, Zhang Z, Yan D, Zheng R, Li F, Wang Y

Infection and Drug Resistance 2025, 18:2703-2716

Published Date: 29 May 2025